Sitemap
- Startpagina
- Diabetes
- Respiratoire aandoeningen
- Zeldzame Bloedziekten
- Neurologie
- Multiple Sclerose
- Artikelen
- Hulpmiddelen
- Events
- Educatie
- Bekijk de video van prof. Veronica Popescu over Smouldering MS - II
- Beyond the Surface: Understanding Smoldering Neuroinflammation
- Smouldering multiple sclerosis
- Slowly Expanded Lesions
- The Important role of microglia in Multiple Sclerosis
- Multiple sclerosis progression: time for a new mechanism-driven framework
- Symposium Smoldering Inflammation in MS
- Beluister de podcast van Prof. Hanneke Hulst over cognitieve achteruitgang
- Preserving cognition in MS
- Thalamic atrophy as a new biomarker of MS?
- Beknopt overzicht AAN 2022 – Een nieuwe kijk op MS
- Listen to Prof. Gavin Giovannoni podcast
- Aubagio® Bigger Picture video
- Bekijk de video over Covid, vaccinaties en DMT's (II)
- Bekijk de video van prof. Veronica Popescu over Smouldering MS - I
- The importance of deep grey matter in MS
- Multiple Sclerose
- Dermatologie
- Atopisch Eczeem
- Artikelen
- Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results1
- Richtlijnen Atopisch Eczeem
- Publicaties op basis van Nederlandse RWE veiligheids- en effectiviteitsdata in de behandeling van atopisch eczeem
- Algemene informatie atopisch eczeem
- Hulpmiddelen
- Events
- Educatie
- Webinarserie - DermaDialogen
- Webinar - Van data naar doen!
- Atopic Dermatitis in Melanin-Rich Skin – A DermTalks Webinar
- Restoring the Barrier Skin Barrier dysfunction in AD
- Introduction to hand and foot dermatitis
- Podcast - Constitutioneel eczeem door dermatologen Marjolein de Bruin-Weller en Marlies de Graaf
- Hot topics in atopic dermatitis: Longterm Control in AD
- Hot topics in atopic dermatitis: Hear it from the experts
- Artikelen
- Atopisch Eczeem bij kinderen
- Prurigo Nodularis
- Atopisch Eczeem
- Cardiologie
- Dyslipidemie
- Artikelen
- PRALUENT is available as a unique,¥ once-monthly pen
- 146 for Lipid Management After ACS
- Approach for patients with peripheral artery disease (PAD) + T2DM: focus on LDL-C control
- What is PRALUENT®?
- Vergoeding Praluent
- Why choose PRALUENT®?
- Cardiovascular diseases (CVDs) are the leading cause of death globally
- 2024 ESC Guidelines for the management of chronic coronary syndromes
- Approach for patients with coronary artery disease (CAD): focus on LDL-C control
- Hulpmiddelen
- Educatie
- Preventive Cardiology: Key Insights from Professor Michal Vrablik
- Why Don’t We Strike Early, Strike Strong?
- A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I
- Understanding Cardiovascular Risk and Prevention: Insights from Professor Pasquale Perrone-Filardi
- Praluent: video's en animaties
- Praluent: podcasts
- Artikelen
- Dyslipidemie
- Zeldzame Ziekten
- Vaccins
- Gastro-enterologie
- Andere onderwerpen
- Producten
- Therapeutische gebieden
- Sitemap
- Registreren
- Log in
- Gebruiksvoorwaarden
- Data Privacy
- Cookieverklaring